Bell_Erica_720x720 Associate Director, Neuroscience Research Institute
Associate Professor, Department of Neurology

Erica.Bell@osumc.edu

Education and Training:

  • PhD: Johns Hopkins University

Research Interests:

  • Genomics
  • Epigenetics
  • Biomarkers
  • Developmental Therapeutics

Clinical Interests:

  • Biomarkers
  • Clinical Trials
  • Brain Tumors
  • Neuro-immunology

Background:
As Associate Director for the Neuroscience Research Institute, Dr. Bell will oversee the biorepository and biomarker efforts for neurological diseases in addition to developing educational, career development, and mentorship programs for junior faculty and trainees. Dr. Bell has been an Associate Professor in the College of Medicine since 2018 and a faculty member within the Translational Therapeutic program in the Comprehensive Cancer Center at Ohio State since 2010. She received her Ph.D. in Biochemistry & Molecular Biology from the Johns Hopkins University and comes to the Neuroscience Research Institute with 10 years of molecular biomarker and adult and pediatric brain tumor experience. She has played a critical role in overseeing multiple projects approved by the NCI-Cancer Therapy Evaluation Program (CTEP) to examine biomarker endpoints on clinical trials. Dr. Bell’s work has been funded by numerous national foundation grants and has been published in high-impact journals such as the New England Journal of Medicine, JAMA Oncology, Journal of Clinical Oncology, and Neuro-oncology. She is a co-inventor on a federal biomarker patent and a grant reviewer for both the AACR and the Department of Defense. Dr. Bell has served as member of the Women in Medicine & Science (WIMS) committee within OSUCOM since 2013 and is a graduate of the OSUCOM Faculty Leadership Institute and in the current class of The President and Provost’s Leadership Institute at OSU. Dr. Bell has been the recipient of a Otterbein University Young Alumni Award for Research and Creative Achievement, OSUCOM Career Development Award for Researchers, Columbus CEO Future 50 Class of 2021 Award, and an American Society of Clinical Oncology Best of Best Award.

Research Link:

NIH: My Bibliography